E.H. Tan

Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma

E.H. Tan, K. Khoo, Joseph Wee et al. · Annals of Oncology · 1999 · 144 citations · Full text

Carboplatin Combination, Phase Ii Trial, Medicine +7

Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors

Wan‐Teck Lim, E.H. Tan, Chee‐Keong Toh et al. · Annals of Oncology · 2009 · 139 citations

Solid Tumors, Medicine, Pharmacology +5

A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma

Whay Kuang Chia, W.-W. Wang, Melissa Ching Ching Teo et al. · Annals of Oncology · 2011 · 138 citations · Full text

Vaccine Safety, Tumor Immunology, Vaccine Development +10

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

Kian Fong Foo, E.H. Tan, Swan Swan Leong et al. · Annals of Oncology · 2002 · 128 citations

Medicine, Nasopharyngeal Cancer, Pathology +4

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

C. Manegold, Nico van Zandwijk, A. Szczęsna et al. · Annals of Oncology · 2011 · 126 citations · Full text

Oncology, Tlr9 Agonist, Medicine +8